St. Louis Trust CO Abb Vie Inc. Transaction History

St. Louis Trust CO

$710 Million
Q3 2024

A detailed history of St. Louis Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, St. Louis Trust CO holds 7,089 shares of ABBV stock, worth $1.28 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

7,089

Previous 8,278 14.36%

Holding current value

$1.28 Million

Previous $1.42 Million 1.41%

% of portfolio

0.2%

Previous 0.22%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$163.84 - $199.33 $194,805 - $237,003	-1,189 Reduced 14.36%	7,089 $1.4 Million
Q1 2024 May 01, 2024	BUY	$159.82 - $182.1 $190,025 - $216,516	1,189 Added 16.77%	8,278 $1.51 Million
Q4 2022 Feb 03, 2023	SELL	$138.31 - $165.87 $8,851 - $10,615	-64 Reduced 0.89%	7,089 $1.15 Million
Q3 2022 Nov 01, 2022	BUY	$134.21 - $153.93 $12,213 - $14,007	91 Added 1.29%	7,153 $766,000
Q2 2022 Aug 01, 2022	BUY	$137.62 - $174.96 $3,165 - $4,024	23 Added 0.33%	7,062 $1.08 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $31,279 - $38,808	-237 Reduced 3.26%	7,039 $1.14 Million
Q4 2021 Feb 07, 2022	BUY	$107.43 - $135.93 $3,330 - $4,213	31 Added 0.43%	7,276 $985,000
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $3,192 - $3,623	30 Added 0.42%	7,245 $782,000
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $3,051 - $3,399	29 Added 0.4%	7,215 $813,000
Q1 2021 Apr 27, 2021	BUY	$102.3 - $112.62 $735,127 - $809,287	7,186 New	7,186 $777,000
Q4 2020 Feb 03, 2021	SELL	$80.49 - $108.67 $573,249 - $773,947	-7,122 Closed	0 $0
Q3 2020 Oct 27, 2020	BUY	$85.91 - $100.83 $2,749 - $3,226	32 Added 0.45%	7,122 $624,000
Q2 2020 Aug 06, 2020	SELL	$73.37 - $98.18 $9,097 - $12,174	-124 Reduced 1.72%	7,090 $696,000
Q1 2020 May 04, 2020	BUY	$64.5 - $97.79 $2,193 - $3,324	34 Added 0.47%	7,214 $549,000
Q4 2019 Feb 05, 2020	BUY	$72.13 - $90.25 $2,308 - $2,888	32 Added 0.45%	7,180 $636,000
Q3 2019 Oct 30, 2019	BUY	$62.98 - $75.72 $2,708 - $3,255	43 Added 0.61%	7,148 $542,000
Q2 2019 Jul 30, 2019	BUY	$65.7 - $83.98 $2,233 - $2,855	34 Added 0.48%	7,105 $517,000
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $2,622 - $3,086	34 Added 0.48%	7,071 $570,000
Q4 2018 Jan 31, 2019	BUY	$77.85 - $96.01 $2,024 - $2,496	26 Added 0.37%	7,037 $649,000
Q3 2018 Oct 31, 2018	BUY	$88.91 - $98.84 $2,222 - $2,471	25 Added 0.36%	7,011 $663,000
Q2 2018 Aug 07, 2018	SELL	$89.78 - $106.23 $536,704 - $635,042	-5,978 Reduced 46.11%	6,986 $648,000
Q1 2018 Apr 23, 2018	BUY	$92.01 - $123.21 $691,455 - $925,923	7,515 Added 137.92%	12,964 $1.23 Million
Q4 2017 Jan 25, 2018	BUY	$89.56 - $98.21 $180,552 - $197,991	2,016 Added 58.72%	5,449 $527,000
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $239,795 - $306,292	3,433	3,433 $305,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of St. Louis Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on St. Louis Trust CO with notifications on news.

Account